犬疫苗市場報告：趨勢、預測和競爭分析（至 2031 年）

未來全球犬疫苗市場很可能在獸醫診所和寵物飼主市場中看到機會。預計到 2031 年全球狗疫苗市場規模將達到 49 億美元，2025 年至 2031 年的複合年成長率為 5.7%。這個市場的主要驅動力是寵物狗數量的增加、飼主對於為寵物狗進行預防性醫療保健的好處的認知不斷提高、以及政府關於疫苗接種的法規。

• Lucintel 預測，由於犬類感染疾病發病率不斷上升，且減毒活病毒疫苗將繼續成為最大的細分市場。
• 在最終用途類別中，預計獸醫醫院和診所將在預測期內實現高速成長。
• 從地區來看，北美可能仍是最大的地區，因為政府對疫苗接種有著嚴格的規定，以保護狗免受嚴重疾病的侵害並保護人類免受狗咬傷。

犬疫苗市場的策略性成長機會

由於技術的進步、寵物擁有率的提高和疫苗宣傳活動的擴大，狗疫苗市場在關鍵應用領域呈現出多種策略成長機會。

• 擴展到新興市場：將犬類疫苗接種計畫擴展到新興市場具有巨大的成長潛力。這樣，他們就可以實現更好的取得和負擔能力，佔領更多的市場佔有率，並減輕狗的疾病負擔。
• 開發多效價疫苗：投資針對不同疾病的多效價疫苗可以簡化疫苗接種過程並提高依從性。
• 更好的疫苗製劑：開發不太可能引起副作用並提供更長時間免疫的新型疫苗製劑具有優勢。利用這些進步可以幫助提高人們對狗疫苗接種的接受度和吸收率。
• 整合數位健康平台：將數位健康平台整合到疫苗分發和追蹤中可以提高疫苗接種率並改善寵物的整體健康狀況。透過這些平台，您可以改善預約安排和庫存管理。
• 創新的疫苗接種方法：開發創新的疫苗接種方法，例如口服疫苗，可以讓飼主更容易接種疫苗。這代表著因疫苗接種增加而機會。

這些機會正在推動與犬疫苗產業相關的公共衛生領域的變革，改善疫苗取得途徑並推動疫苗技術。

犬疫苗市場促進因素與挑戰

技術進步、經濟因素和監管考量是影響犬疫苗市場的一些促進因素和挑戰。因此，了解這些因素對於了解市場格局至關重要。

推動犬疫苗市場發展的因素有：

• 寵物擁有量的增加：全球寵物數量的不斷成長是狗疫苗需求的主要驅動力。隨著越來越多的家庭擁有寵物，包括疫苗接種在內的預防性護理的需求正在推動市場成長。
• 技術進步：疫苗技術的改進，例如多效價疫苗和口服給藥選擇，進一步增加了需求。這些發展使得疫苗更加有效和方便，確保了疫苗接種的增加。
• 政府宣傳活動：政府主導的疫苗宣傳活動，尤其是在新興國家，正在推動狗疫苗的銷售。這些宣傳活動有助於控制狂犬病等疾病並促進市場擴張。
• 擴大獸醫基礎設施：獸醫服務和設施的擴大，特別是在新興市場，為犬類疫苗的接種提供了更多管道。獸醫基礎設施的改善使更多的寵物能夠及時接種疫苗，從而支持了整體市場的成長。

犬疫苗市場面臨的挑戰是：

• 經濟限制：經濟限制：疫苗生產成本及其定價等經濟問題可能會導致該細分市場的波動。在擴張的過程中，實現成本和品質之間的平衡對於保持競爭力至關重要。
• 監管障礙：遵守嚴格的疫苗核准和安全法規是一項挑戰。滿足這些要求對於進入目標市場和開發產品至關重要，但它會減慢進程並增加成本。
• 疫苗接種不願意：飼主不願意接種疫苗是該行業發展的一大限制因素。解決對疫苗安全性和有效性的擔憂可以顯著提高疫苗接種率並擴大整體市場。

這些市場促進因素和挑戰透過決定產品開發、市場範圍和法規遵循來塑造犬疫苗市場。

目錄

第1章執行摘要

第 2 章。

• 簡介、背景和分類
• 供應鏈
• 產業促進因素與挑戰

第 3 章 市場趨勢與預測分析（2019-2031）

• 宏觀經濟趨勢（2019-2024）與預測（2025-2031）
• 全球犬疫苗市場趨勢（2019-2024 年）及預測（2025-2031 年）
• 全球犬類疫苗市場類型
  • 減毒活病毒疫苗
  • 結合疫苗
  • 去活化疫苗
  • 次單位疫苗
  • 類毒素疫苗
  • DNA疫苗
  • 重組疫苗
• 全球犬類疫苗市場（依年齡分類）
  • 少於 6 個月
  • 6個月或以上
• 全球犬類疫苗市場（依最終用途分類）
  • 獸醫診所
  • 寵物飼主
  • 其他

第 4 章區域市場趨勢與預測分析（2019-2031 年）

• 全球犬疫苗市場（按地區）
• 北美犬類疫苗市場
• 歐洲犬類疫苗市場
• 亞太犬類疫苗市場
• 世界其他地區犬類疫苗市場

第5章 競爭分析

• 產品系列分析
• 營運整合
• 波特五力分析

第6章 成長機會與策略分析

• 成長機會分析
  • 全球犬疫苗市場成長機會（按類型）
  • 全球犬疫苗市場按年齡分類的成長機會
  • 全球犬疫苗市場成長機會（依最終用途分類）
  • 全球犬疫苗市場成長機會（按地區）
• 全球犬疫苗市場的新趨勢
• 戰略分析
  • 新產品開發
  • 全球犬疫苗市場產能擴大
  • 全球犬疫苗市場的企業合併
  • 認證和許可

第7章主要企業簡介

• Bayer
• Vetquinol
• Boehringer Ingelhiem
• Ceva
• Eli Lilly
• Heska
• Merck

The future of the global dog vaccine market looks promising with opportunities in the veterinary hospital & clinic and pet owner markets. The global dog vaccine market is expected to reach an estimated $4.9 billion by 2031 with a CAGR of 5.7% from 2025 to 2031. The major drivers for this market are the increasing adoption of pet dogs, growing awareness among pet owners about the benefits of preventive healthcare for their dogs, and government regulations for vaccinations.

• Lucintel forecasts that, within the type category, attenuated live will remain the largest segment due to the rising incidence of infectious diseases among dogs, as well as the convenience and effectiveness of this vaccine compared to others.
• Within the end-use category, veterinary hospitals & clinics are expected to witness higher growth over the forecast period.
• In terms of regions, North America will remain the largest region due to strict government regulations regarding vaccination to protect dogs from serious diseases, as well as to protect human life from dog biting.

Gain valuable insights for your business decisions with our comprehensive 150+ page report.

Emerging Trends in the Dog Vaccine Market

Dog vaccines are significantly changing due to evolving consumer tastes, technological developments, and increased awareness of dog health. The demand for innovative and efficient vaccines is rising as the incidence of pet ownership continues to increase globally. Several trends will shape the market and influence the development, distribution, and administration of vaccines.

• Manifold Vaccines: The trend toward manifold vaccines that protect dogs from numerous diseases with just one injection is growing. This simplifies the vaccination process, enhances compliance, and reduces stress for both dogs and owners.
• Digital Health Platforms: The integration of digital health platforms has revolutionized vaccine distribution and tracking. These platforms improve inventory management, appointment scheduling, and follow-up reminders, thereby increasing vaccination rates and overall pet health.
• Global Expansion of Pet Ownership: The rise in pet ownership in emerging markets is driving increased demand for dog vaccines. More households are acquiring pets in nations such as China and India, resulting in an expanding market for vaccines and increased production and distribution.
• Focus on Vaccine Safety and Efficacy: Attention is rising regarding the safety and effectiveness of dog vaccines. More stringent regulations have been established by regulatory bodies to ensure that these products are not only safe for pets but also effective in preventing diseases.
• Innovative Vaccine Delivery Methods: Oral vaccines and other novel delivery techniques are gaining popularity. These methods make it easier for pet owners to vaccinate their animals, thereby reducing the anxiety often associated with injectable vaccines.

These trends are reshaping the dog vaccine market by enhancing vaccine technology, expanding access, and improving overall pet health.

Recent Developments in the Dog Vaccine Market

The dog vaccine market is experiencing several key developments that spur growth and innovation in canine healthcare.

• Development of Multi-Valent Vaccines: Companies are introducing multi-valent vaccines that prevent various diseases with one shot. This makes the vaccination process easier and achieves higher compliance among pet owners.
• Expansion of Vaccine Access in Emerging Markets: Ongoing efforts aim to expand access to dog vaccines in emerging markets. This expansion is fueled by increased pet ownership and government initiatives aimed at controlling diseases like rabies.
• Advancements in Vaccine Formulations: Recent advances in vaccine formulations have resulted in more effective vaccines with fewer side effects. These improvements enhance vaccine performance and increase acceptance among pet owners.
• Integration of Digital Health Platforms: Vaccination rates are improving through the adoption of digital health platforms for vaccine distribution and tracking. These platforms facilitate better inventory management, appointment scheduling, and follow-up reminders.
• Innovation in Vaccine Delivery Methods: New vaccine delivery methods, such as oral vaccines, are being developed to simplify the process of vaccinating dogs. These innovations will increase vaccine uptake and improve overall pet health.

By enhancing vaccine technology, increasing access, and improving overall pet health, these developments propel the dog vaccine market forward.

Strategic Growth Opportunities for Dog Vaccine Market

The dog vaccine market presents several strategic opportunities for growth across major applications due to technological improvements, rising pet ownership, and expanding immunization campaigns.

• Emerging Markets Expansion: There is significant potential for growth in extending dog vaccination programs to emerging markets. By doing so, better access and affordability can be achieved, capturing more market share and reducing the canine disease burden.
• Development of Multi-Valent Vaccines: Investing in multi-valent vaccines that target various diseases can simplify the vaccination process and boost adherence, offering additional revenue opportunities by increasing attractiveness to buyers.
• Better Vaccine Formulations: The creation of new vaccine formulations that are less likely to cause side effects while providing longer immunity has its advantages. Utilizing these advancements can encourage the acceptance and use of dog vaccinations.
• Digital Health Platform Integration: Integrating digital health platforms into vaccine distribution and tracking leads to improved vaccination rates and enhances pets' overall health. Improved appointment scheduling and inventory management can be facilitated through these platforms.
• Innovative Methods of Vaccine Delivery: Developing innovative methods of vaccine delivery, such as oral vaccines, makes vaccination easier for owners. This represents an opportunity for growth through increased vaccine uptake.

These opportunities are driving changes in access improvements and advancing vaccine technology within the public health sector related to the dog vaccine industry.

Dog Vaccine Market Driver and Challenges

Technological advancements, economic factors, and regulatory considerations are among the drivers and challenges influencing the dog vaccine market. Therefore, it is essential to understand these elements to navigate the market landscape.

The factors driving the dog vaccine market include:

• Increased Number of Pet Owners: The global rise in pet ownership is a significant force behind the demand for dog vaccines. As more families keep pets, they require preventive care, including vaccinations, fostering market growth.
• Technological Advances: Improvements in vaccine technology, such as multi-valent vaccines and oral administration options, have further increased demand. These developments make vaccines more effective and convenient, ensuring higher adoption rates.
• Government Campaigns: Government-led vaccination initiatives, particularly in emerging economies, have boosted dog vaccine sales. These campaigns help manage diseases like rabies, contributing to market expansion.
• Expanding Veterinary Infrastructure: The expansion of veterinary services and facilities, particularly in emerging markets, is facilitating greater access to dog vaccines. Improved veterinary infrastructure ensures that more pets receive timely vaccinations, supporting overall market growth.

Challenges in the dog vaccine market include:

• Financial Constraints: Economic issues, such as the cost of manufacturing vaccines and their affordability, can cause fluctuations within this market segment. It is imperative to balance cost and quality to remain competitive while expanding.
• Regulatory Hurdles: Compliance with strict regulations regarding vaccine approval and safety can be challenging. Meeting these requirements is essential for gaining access to target markets and developing products, which can delay processes and increase costs.
• Reluctance Toward Vaccination: Pet owners' hesitancy toward vaccinations poses a barrier to growth in this industry. Addressing concerns about vaccine safety and effectiveness can significantly raise immunization coverage and expand the overall market.

These drivers and challenges define product development, market growth, and regulatory compliance, thereby shaping the dog vaccine market.

List of Dog Vaccine Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies dog vaccine companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the dog vaccine companies profiled in this report include-

• Bayer
• Vetquinol
• Boehringer Ingelhiem
• Ceva
• Eli Lilly
• Heska
• Merck

Dog Vaccine by Segment

The study includes a forecast for the global dog vaccine market by type, age, end use, and region.

Dog Vaccine Market by Type [Analysis by Value from 2019 to 2031]:

• Attenuated Live Vaccines
• Conjugate Vaccines
• Inactivated Vaccines
• Subunit Vaccines
• Toxoid Vaccines
• DNA Vaccines
• Recombinant Vaccine

Dog Vaccine Market by Age [Analysis by Value from 2019 to 2031]:

• Below 6 Months
• Above 6 Months

Dog Vaccine Market by End Use [Analysis by Value from 2019 to 2031]:

• Veterinary Hospitals & Clinics
• Pet Owners
• Others

Dog Vaccine Market by Region [Analysis by Value from 2019 to 2031]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

Country Wise Outlook for the Dog Vaccine Market

Improvements in pet ownership, growing awareness of dog health, and technological advancements are contributing to significant progress in the dog vaccine sector. Vaccine formulations, distribution channels, and government initiatives guiding dog vaccination rates and general pet healthcare are undergoing notable changes in key markets such as the US, China, Germany, India, and Japan.

• United States: There is increased demand for multi-valent dog vaccines that protect against multiple diseases, reducing the number of injections required. Additionally, digital platforms are being adopted to enhance vaccine distribution and monitoring, thus improving overall vaccination compliance rates and coverage.
• China: China is experiencing rapid growth in the dog vaccine market due to its expanding middle class, resulting in a higher number of pets owned per household. The government has launched various campaigns aimed at controlling rabies and other diseases, while local manufacturers are diversifying their product range to meet rising demands.
• Germany: Research activities targeting new canine diseases are prevalent in Germany. The country has also tightened quality control requirements to ensure that all newly developed vaccines meet high standards before being sold.
• India: The Indian dog vaccine market is growing due to the introduction of low-cost vaccines, particularly for rural communities. Government initiatives are facilitating widespread rabies vaccinations, while private sector players are entering vaccine manufacturing and distribution to meet current needs.
• Japan: Japan has advanced in creating innovative vaccine forms, including oral vaccines, which simplify the vaccination process for pet owners. Furthermore, the nation has improved its regulatory framework regarding safe and effective vaccine development, supporting a rise in preventive pet healthcare.

Features of the Global Dog Vaccine Market

Market Size Estimates: Dog vaccine market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2019 to 2024) and forecast (2025 to 2031) by various segments and regions.

Segmentation Analysis: Dog vaccine market size by type, age, end use, and region in terms of value ($B).

Regional Analysis: Dog vaccine market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different types, ages, end uses, and regions for the dog vaccine market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the dog vaccine market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

If you are looking to expand your business in this or adjacent markets, then contact us. We have done hundreds of strategic consulting projects in market entry, opportunity screening, due diligence, supply chain analysis, M & A, and more.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the dog vaccine market by type (attenuated live vaccines, conjugate vaccines, inactivated vaccines, subunit vaccines, toxoid vaccines, DNA vaccines, and recombinant vaccine), age (below 6 months and above 6 months), end use (veterinary hospitals & clinics, pet owners, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Dog Vaccine Market : Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2019 to 2031

• 3.1. Macroeconomic Trends (2019-2024) and Forecast (2025-2031)
• 3.2. Global Dog Vaccine Market Trends (2019-2024) and Forecast (2025-2031)
• 3.3: Global Dog Vaccine Market by Type
  • 3.3.1: Attenuated Live Vaccines
  • 3.3.2: Conjugate Vaccines
  • 3.3.3: Inactivated Vaccines
  • 3.3.4: Subunit Vaccines
  • 3.3.5: Toxoid Vaccines
  • 3.3.6: DNA Vaccines
  • 3.3.7: Recombinant Vaccine
• 3.4: Global Dog Vaccine Market by Age
  • 3.4.1: Below 6 months
  • 3.4.2: Above 6 months
• 3.5: Global Dog Vaccine Market by End Use
  • 3.5.1: Veterinary Hospitals & Clinics
  • 3.5.2: Pet Owners
  • 3.5.3: Others

4. Market Trends and Forecast Analysis by Region from 2019 to 2031

• 4.1: Global Dog Vaccine Market by Region
• 4.2: North American Dog Vaccine Market
  • 4.2.1: North American Market by Type: Attenuated Live Vaccines, Conjugate Vaccines, Inactivated Vaccines, Subunit Vaccines, Toxoid Vaccines, DNA Vaccines, and Recombinant Vaccine
  • 4.2.2: North American Market by End Use: Veterinary Hospitals & Clinics, Pet Owners, and Others
• 4.3: European Dog Vaccine Market
  • 4.3.1: European Market by Type: Attenuated Live Vaccines, Conjugate Vaccines, Inactivated Vaccines, Subunit Vaccines, Toxoid Vaccines, DNA Vaccines, and Recombinant Vaccine
  • 4.3.2: European Market by End Use: Veterinary Hospitals & Clinics, Pet Owners, and Others
• 4.4: APAC Dog Vaccine Market
  • 4.4.1: APAC Market by Type: Attenuated Live Vaccines, Conjugate Vaccines, Inactivated Vaccines, Subunit Vaccines, Toxoid Vaccines, DNA Vaccines, and Recombinant Vaccine
  • 4.4.2: APAC Market by End Use: Veterinary Hospitals & Clinics, Pet Owners, and Others
• 4.5: ROW Dog Vaccine Market
  • 4.5.1: ROW Market by Type: Attenuated Live Vaccines, Conjugate Vaccines, Inactivated Vaccines, Subunit Vaccines, Toxoid Vaccines, DNA Vaccines, and Recombinant Vaccine
  • 4.5.2: ROW Market by End Use: Veterinary Hospitals & Clinics, Pet Owners, and Others

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global Dog Vaccine Market by Type
  • 6.1.2: Growth Opportunities for the Global Dog Vaccine Market by Age
  • 6.1.3: Growth Opportunities for the Global Dog Vaccine Market by End Use
  • 6.1.4: Growth Opportunities for the Global Dog Vaccine Market by Region
• 6.2: Emerging Trends in the Global Dog Vaccine Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global Dog Vaccine Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Dog Vaccine Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: Bayer
• 7.2: Vetquinol
• 7.3: Boehringer Ingelhiem
• 7.4: Ceva
• 7.5: Eli Lilly
• 7.6: Heska
• 7.7: Merck